Fennec Pharmaceuticals (FENC US)

Health Care • Canada

Fennec Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of Sodium Thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients.

Refresh

No publications yet

No AI primers are available right now. Create one using Smartkarma AI.

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00